Data Privacy Legislation Picking Up Speed: State and Federal Update
The data privacy landscape in the U.S. is continuing to change rapidly.
Trump Holding Big Pharma Accountable In Opioid Fight
U.S. President Donald Trump touted progress in the fight against opioid abuse and promised to hold drugmakers accountable for their part in the crisis, a day after his administration brought its first related criminal charges against a major drug distributor and company executives.
After drug distributor charged, Trump sets speech on opioid fight
President Donald Trump is expected to tout his fight against opioid abuse in remarks in Atlanta a day after his administration brought its first related criminal charges against a major drug distributor and company executives.
White House Continues to Tackle Opioid Abuse With $350 Million R&D Initiative
The White House is expanding its war on opioid addiction with a $350 million addiction research and treatment initiative.
Swiss drugmaker Roche ups outlook as sales growth offsets price hit
Roche lifted the Swiss drugmaker’s 2019 outlook as sales growth in China and the United States outpaced price declines the company has suffered amid President Donald Trump’s pressure on the industry to hold down charges.
Bernie Sanders puts focus on healthcare with Medicare for All bill
U.S. Senator Bernie Sanders unveiled the latest version of his ambitious “Medicare-for-All” plan, moving the healthcare debate among Democratic presidential contenders to center stage in the 2020 race.
Democrats welcome fight as Trump tees up 2020 healthcare battle
Democrats embraced U.S. President Donald Trump’s call to revive a fight over healthcare coverage, ensuring a prominent role for the issue in the 2020 election as Trump seeks a second term in office.
China expands curbs on fentanyl, blames U.S. for its abuse
China will expand the range of fentanyl-related substances the country defines as controlled narcotics, a Chinese security official said, blaming U.S. culture for abuse of the drug.
Trump wants to work with Democrats on drug prices, infrastructure: aide
U.S. President Donald Trump is willing to work with congressional Democrats to lower drug prices for Americans and on infrastructure funding, White House adviser Kellyanne Conway said.
U.S. FDA chief steps down abruptly
FDA Commissioner Scott Gottlieb plans to step down in April 2019, a sudden resignation that calls into question how the regulatory agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!